LL-37

🔹 What is LL-37?

Class: Antimicrobial host defense peptide (human cathelicidin). LL-37 is a 37-amino-acid antimicrobial peptide derived from the human cathelicidin protein hCAP18. Mechanism:

• Exhibits broad-spectrum antimicrobial activity against bacteria, viruses, and fungi.
• Modulates the immune response by promoting chemotaxis, angiogenesis, and wound healing.
• Enhances tissue repair through immunomodulatory and regenerative signaling pathways.

Primary focus:

• Wound healing, tissue regeneration, and antimicrobial defense.
• Potential therapeutic applications in skin infections, chronic wounds, and immune support.

---

🔹 Oral Dosage: Not effective; peptide is degraded in the GI tract. Only injectable, subcutaneous, or topical routes are practical.

---

🔹 Injectable / Subcutaneous Dosage (most common) Range:

• Typical dosing in research: 50–200 µg per injection, 1–2x daily depending on severity and target tissue.

Frequency:

• Often administered daily for acute wound or infection management.

Rationale: Microgram-level dosing ensures antimicrobial and regenerative effects without systemic toxicity.

---

🔹 Topical Dosage (for skin or localized wounds)

• Typical topical formulations: 0.05–0.2% LL-37 cream or gel, applied 1–2x daily to the affected area.
• Useful for chronic wounds, ulcers, or localized infection/inflammation.

Notes: Topical administration targets local tissue repair and antimicrobial activity directly at the site of injury.

---

🔹 Cycle Length Common cycle length: 2–6 weeks depending on wound healing or antimicrobial needs. Off-cycle: 1–2 weeks to monitor healing and tissue response.

---

🔹 Optimal Dosing Window

• Injectable: Morning or early afternoon to align with tissue repair cycles.
• Topical: Morning and/or evening for targeted wound management.

---

✅ Educational Integration Example

• Injectable: 100 µg subcutaneous daily for 4 weeks for systemic support.
• Topical: 0.1% LL-37 gel applied twice daily to chronic wounds.
• Can be paired with BPC-157, TB-500, GHK-Cu, or other regenerative peptides for enhanced tissue repair.

---

🔹 Stacking Strategy (Educational / Complementary) Since LL-37 supports antimicrobial defense and tissue repair, complementary stacks focus on regenerative support, immune modulation, and localized healing: 🔸 Tissue Regeneration & Repair:

• BPC-157, TB-500, GHK-Cu: Promote connective tissue, angiogenesis, and skin repair.
• Collagen peptides / Vitamin C: Support extracellular matrix remodeling.

🔸 Immune Support:

• Vitamin D, zinc, NAC: Enhance innate immunity and antioxidant defense.

🔸 Anti-inflammatory & Recovery Support:

• KPV, Epitalon, NAD⁺ precursors: Reduce inflammation and support cellular repair pathways.

Rationale: LL-37 enhances local and systemic tissue repair while providing antimicrobial protection; stacking focuses on synergistic regenerative and immune-supportive pathways without overlapping mechanisms.

Disclaimer: Do not rely on any dosing information provided, this is for educational and research only. Always double and triple check alternative references for education. Please consult with healthcare provider for your specific dosing and protocol if applicable.